Athanor Capital, LP Ionis Pharmaceuticals Inc Transaction History

Athanor Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$42.51 - $63.78 $174,503 - $261,816	-4,105 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$45.3 - $60.27 $224,914 - $299,240	-4,965 Reduced 54.74%	4,105 $232,000
Q3 2020 Nov 16, 2020	SELL	$47.45 - $62.95 $546,481 - $724,995	-11,517 Reduced 55.94%	9,070 $430,000
Q2 2020 Aug 13, 2020	BUY	$46.85 - $61.05 $964,500 - $1.26 Million	20,587 New	20,587 $1.21 Million
Q1 2020 May 14, 2020	SELL	$41.6 - $63.4 $426,108 - $649,406	-10,243 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $551,585 - $668,560	10,243 New	10,243 $619,000

404

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.1B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.